News Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,...
News George Shultz Innovation Fund Invest in Anapneo Therapeutics at Its Spring Finals Finalists presented their proposals to the Innovation Fund advisory committee at the finals on June 5.
News Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University...
News U of C Startup Seurat Therapeutics Announces $510K in Grant Funding Seurat Therapeutics, Inc. is a University of Chicago startup biotech company developing a nasal spray to treat and prevent migraines
Technology Self-assembling Nanofibril Particles for Controlled Release of IV and SUBQ Therapeutics Clinically approved methods for the controlled release of oral therapies have demonstrated their efficacy in reducing required dosage, administration frequency, and side effects, thereby boosting patient compliance. Despite these successes,…
Technology Senolytic Therapeutics To Eliminate Senescent Cells And Enhance Aging And Cancer Treatments Targeted approach to remove aging, disease-related, or chemotherapy/immunotherapy-induced senescent cells while sparing healthy cells The Unmet Need: Approaches to selectively eliminate senescent cells improving aging symptoms without damaging healthy…
News Innovation Fund Invests $575,000 in Biotech Companies The University of Chicago Innovation Fund announced plans to invest up to $575,000 into three biotechnology companies—ImmunArtes, Onchilles Pharma, and Oxalo Therapeutics. These latest investments bring the Innovation Fund’s total...
News Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round Momentum continues to build for Alnair Therapeutics, an oncology startup focused on developing a platform to better deliver drugs to hard-to-treat cancers. In June – the same month that the...
Technology Rapid Selection Of High-Value Internalizing Binders For Targeted Therapeutics Lentiviral display platform engineered to directly select and enrich antibodies based on their ability to induce receptor-mediated endocytosis, thereby streamlining the discovery of highly internalizing candidates for targeted therapies The…
News NanoPattern Technologies, ReAx Biotechnologies Receive $150,000 Each to Commercialize Research The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has chosen two companies – NanoPattern Technologies and ReAx Biotechnologies – to invest in as part of the...
News Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program The Polsky Center for Entrepreneurship and Innovation recently launched the Compass – a first-of-its-kind deep tech accelerator program for early-stage startups and technologies. “Backed by a 25-year history of launching...
News 50 Companies to Pitch to Investors at DeepTechU The DeepTechU venture conference will showcase 50 startups during the three-day virtual event May 3 to 5, giving investors an early look at cutting-edge deep tech innovation coming out of universities,...
